Health Industry News
New parents unintentionally placing their babies at risk of SIDS
Many new parents are unknowingly placing their babies at risk of SIDS, according to new research released by the American Academy of Pediatrics on August 15, 2016. The researchers examined video recordings of parents putting their babies to sleep, rather than relying on parental self-reported surveys or police reports post-mortem. More than 160 infants were…
Read MoreGovernment to list plethora of treatments for Type 2 diabetes & cervical cancer on PBS from September 1, 2016 – August 22, 2016
On August 14, 2016, Federal Health Minister, The Hon. Sussan Ley MP announced up to 20,000 Australians living with Type 2 diabetes would find it easier and cheaper to access treatments with the Government’s listing of AUD $70 million in new therapies on the Pharmaceutical Benefits Scheme (PBS) from September 1, 2016. A new, once-a-week…
Read MoreWhat does the King Review mean for Pharmacy in Australia – August 5, 2016
Following the release of a discussion paper dubbed the “King Review” (as the Productivity Commission’s, Stephen King headed the review panel), which has been developed to review pharmacy remuneration and regulation procedures, discussions have opened up this week around what the review recommends and how this can impact pharmacy. The Federal Government and the Pharmacy…
Read MoreBREAKING NEWS: Chemmart & Terry White Merger anticipated end of October – August 4, 2016
This morning (August 4, 2016), EBOS Group Limited announced plans to merge its Chemmart business with the Terry White Group businesses, in order to create one of Australia’s largest retail pharmacy groups. In an EBOS investor release published today (August 4, 2016), the wholesaler announced the merge of Chemmart with Terry White would equate to…
Read MoreAustralia’s only locally manufactured QIV now TGA approved – August 2, 2016
Australia’s only locally manufactured, quadrivalent seasonal influenza vaccine (QIV) received Therapeutic Goods Administration (TGA) approval on July 15, 2016. Afluria Quad™, Seqirus’ four-strain, inactivated seasonal influenza vaccine, is indicated for people aged 18 years and older.1 The new quadrivalent vaccine will replace the company’s trivalent vaccine (TIV), Fluvax® for the 2017 flu season. Manufactured by…
Read More